QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 9 August 2006
doi: 10.1242/dev.02501

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: dev.02501v1 133/18/3499    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ang, S.-L. Search for Related Content PubMed PubMed Citation Articles by Ang, S.-L.

Transcriptional control of midbrain dopaminergic neuron development

Division of Developmental Neurobiology, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.

e-mail: sang{at}nimr.mrc.ac.uk

SUMMARY

Although loss of midbrain dopaminergic neurons is associated with one of the most common human neurological disorders, Parkinson's disease, little is known about the specification of this neuronal subtype. Hence, the recent identification of major transcriptional determinants regulating the development of these neurons has brought much excitement and encouragement to this field. These new findings will help to elucidate the genetic program that promotes the generation of midbrain dopaminergic neurons. Importantly, these discoveries will also significantly advance efforts to differentiate stem cells into midbrain dopaminergic neurons that can be used for therapeutic use in treating Parkinson's disease.

This article has been cited by other articles:

				A. L. M. Ferri, W. Lin, Y. E. Mavromatakis, J. C. Wang, H. Sasaki, J. A. Whitsett, and S.-L. Ang Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner Development, August 1, 2007; 134(15): 2761 - 2769. [Abstract] [Full Text] [PDF]